staurosporine aglycone has been researched along with Hamartoma in 1 studies
staurosporine aglycone: metabolite from culture broth of Nocardiopsis sp.; a neurotrophin antag; inhibits BDNF TrkB receptor
Hamartoma: A focal malformation resembling a neoplasm, composed of an overgrowth of mature cells and tissues that normally occur in the affected area.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Semaan, S | 1 |
| Wu, J | 1 |
| Gan, Y | 1 |
| Jin, Y | 1 |
| Li, GH | 1 |
| Kerrigan, JF | 1 |
| Chang, YC | 1 |
| Huang, Y | 1 |
1 other study available for staurosporine aglycone and Hamartoma
| Article | Year |
|---|---|
Hyperactivation of BDNF-TrkB signaling cascades in human hypothalamic hamartoma (HH): a potential mechanism contributing to epileptogenesis.
Topics: Adolescent; Adult; Brain-Derived Neurotrophic Factor; Carbazoles; Child; Child, Preschool; Down-Regu | 2015 |